VTV Therapeutics reports lower net loss after decreasing expenses
High Point biopharma VTVT sees positive results for treatment of mild Alzheimer’s, cuts losses.
Read MorePosted by WRAL TechWire | Nov 9, 2018
High Point biopharma VTVT sees positive results for treatment of mild Alzheimer’s, cuts losses.
Read MorePosted by WRAL TechWire | Apr 17, 2018
Cambrex Corp., a contract manufacturer of small molecules and active pharmaceutical ingredients (APIs) for drug clinical trials, is expanding again in High Point to meet growing business demand for its services.
Read More